NO20070976L - Pyrazolderivater - Google Patents

Pyrazolderivater

Info

Publication number
NO20070976L
NO20070976L NO20070976A NO20070976A NO20070976L NO 20070976 L NO20070976 L NO 20070976L NO 20070976 A NO20070976 A NO 20070976A NO 20070976 A NO20070976 A NO 20070976A NO 20070976 L NO20070976 L NO 20070976L
Authority
NO
Norway
Prior art keywords
formula
salt
cox
pyrazole
compound
Prior art date
Application number
NO20070976A
Other languages
English (en)
Norwegian (no)
Inventor
Naoaki Kanaya
Toshiyuki Watanabe
Takashi Ishiyama
Yuichi Ochiai
Ryo Muto
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20070976L publication Critical patent/NO20070976L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20070976A 2004-08-06 2007-02-21 Pyrazolderivater NO20070976L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004230012 2004-08-06
PCT/JP2005/014544 WO2006014005A1 (fr) 2004-08-06 2005-08-08 Derive de pyrazole

Publications (1)

Publication Number Publication Date
NO20070976L true NO20070976L (no) 2007-04-24

Family

ID=35787279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070976A NO20070976L (no) 2004-08-06 2007-02-21 Pyrazolderivater

Country Status (12)

Country Link
US (1) US20070254881A1 (fr)
EP (1) EP1785418A4 (fr)
JP (1) JPWO2006014005A1 (fr)
KR (1) KR20070048771A (fr)
CN (1) CN101001852A (fr)
AU (1) AU2005268023A1 (fr)
CA (1) CA2578261A1 (fr)
IL (1) IL180889A0 (fr)
MX (1) MX2007001555A (fr)
NO (1) NO20070976L (fr)
RU (1) RU2007108296A (fr)
WO (1) WO2006014005A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002563A1 (fr) * 2005-06-27 2007-01-04 Exelixis, Inc. Régulateurs de lxr de type imidazole
JP2009184925A (ja) * 2006-11-02 2009-08-20 Dai Ichi Seiyaku Co Ltd 5−(1h−1,2,3−トリアゾール−4−イル)−1h−ピラゾール誘導体
US7977358B2 (en) * 2007-07-26 2011-07-12 Hoffmann-La Roche Inc. Pyrazol derivatives
WO2012139930A1 (fr) 2011-04-11 2012-10-18 Nerviano Medical Sciences S.R.L. Dérivés pyrazolyl-pyrimidine en tant qu'inhibiteurs des kinases
CN102321045B (zh) * 2011-06-13 2013-07-17 陕西瑞科新材料股份有限公司 一种制备高吗啉盐酸盐的方法
EP3842100A1 (fr) 2019-12-24 2021-06-30 The Board Of Regents Of The University Of Texas System Agents anti-paludiques
CN114920682A (zh) * 2022-03-17 2022-08-19 重庆医药高等专科学校 一种将脯氨酸还原成脯氨醇的方法及1-甲基吡咯烷-2-丙烯酸的制备方法
CN120463596B (zh) * 2025-07-11 2025-10-21 昆山协鑫光电材料有限公司 一种pcbm及其制备方法和应用以及用于制备pcbm的装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2489428A1 (fr) * 2002-06-27 2004-01-08 Nitromed, Inc. Inhibiteurs selectifs de la cyclooxygenase 2, compositions associees et methodes d'utilisation
PL377848A1 (pl) * 2003-02-07 2006-02-20 Daiichi Pharmaceutical Co., Ltd. Pochodne pirazoli
PL378841A1 (pl) * 2003-04-21 2006-05-29 Daiichi Pharmaceutical Co., Ltd. Pochodna pięcioczłonowego układu heterocyklicznego
RU2007103831A (ru) * 2004-07-01 2008-08-10 Дайити Фармасьютикал Ко., Лтд. (JP) Производные пиразола

Also Published As

Publication number Publication date
US20070254881A1 (en) 2007-11-01
CA2578261A1 (fr) 2006-02-09
AU2005268023A1 (en) 2006-02-09
JPWO2006014005A1 (ja) 2008-05-01
EP1785418A1 (fr) 2007-05-16
RU2007108296A (ru) 2008-09-20
KR20070048771A (ko) 2007-05-09
CN101001852A (zh) 2007-07-18
WO2006014005A1 (fr) 2006-02-09
IL180889A0 (en) 2007-07-04
EP1785418A4 (fr) 2009-11-11
MX2007001555A (es) 2007-04-10

Similar Documents

Publication Publication Date Title
NO20070457L (no) Pyrazolderivater
EA200401613A1 (ru) Лекарственное средство для лечения рака
NO20070731L (no) Heterocykliske forbindelser.
DK1532145T3 (da) Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
MXPA06013534A (es) Compuesto de cinamida.
NO20075987L (no) Bisykliske derviater som p38-kinaseinhibitorer
NO20063090L (no) Amidopyrazolderivater
ATE478859T1 (de) Pyrazolderivat
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
NO20044995L (no) Heterosykliske forbindelser
ATE554065T1 (de) Sulfoniumsalz-fotoinitiatoren
MX2012003392A (es) Nuevo derivado de fenol.
MY150781A (en) Phthalazine derivatives as parp inhibitors
MY144048A (en) Chemical compound
NO20081551L (no) Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme
NO20071826L (no) 1,5-diheterosykel-1H-triazolderivat
NO20083390L (no) Piperaziner og piperidiner som mGluR5-forsterkere
MX2009000675A (es) Concentrados acuosos de principios activos con efecto herbicida.
NO20060426L (no) Kannabinoid reseptormodulator
WO2005053403A3 (fr) Utilisation de derives de n-arylhydrazine pour lutter contre les parasites
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
DE60319080D1 (de) Phenyloxyalkansäure-derivate als hppar aktivatore
TW200640916A (en) (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, their preparation and their application in therapeutics
TW200504049A (en) 5-memtered heterocyclic derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application